Trending News Today: CVS, Aetna Merger Moving Forward in 2018

Early this morning, the House approved budget legislation that will reopen the government and greatly affect health care, according to The New York Times. Under the deal, an advisory board that controls Medicare spending will be repealed and community health centers will gain funding, according to the article. The Medicare panel was implemented under the Affordable Care Act with a goal of addressing the rising costs of the program, the Times reported.

CVS Health still expects to acquire Aetna in the second half of 2018, despite antitrust regulators requesting more information about the merger, Reuters reported. The $69 billion deal is expected to have a significant impact on health care. A shareholder meeting would be held in March to vote on the acquisition, according to the article.

The influenza virus has been evading vaccines, which has resulted in a high burden of hospitalization and mortality. Manufacturers have developed new, promising flu drugs that will be available in the United States next winter, according to Bloomberg. These drugs will provide more treatment options for the hundreds of thousands of patients affected by seasonal and pandemic flu, according to the article.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

Top news of the day across the health care landscape.
A look at last week's top stories in the world of pharmacy.
Two pharmacist groups jointly filed a motion urging the federal judge to block CVS and Aetna from further integration while the potential negative effects are assessed.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.